Anil Kumar Singhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anil Kumar Singhi has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Kothandam Sivakumar
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, Tamil Nadu, India
15 shared publications Arnab De
Department of Cardiology, Manipal Hospitals, Kolkata, West Bengal, India
11 shared publications- Raman Krishna Kumar
Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham , Ponekkara, Edappally, Kochi, Kerala 682041
10 shared publications - Soumya Kanti Mohapatra
Department of Pediatric Cardiology, Medica Superspecialty Hospital, Kolkata, India
8 shared publications Edwin Francis
6 shared publicationsSoumya Kanti Mohapatra
Department of Pediatric and Congenital Heart disease, Medica Super Specialty Hospital, Kolkata, India
6 shared publications
Latest Publications
- 30 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-4
When the skin speaks but the heart remains silent: acute rheumatic fever with three major Jones manifestations without carditis
Acute rheumatic fever is classically associated with carditis, particularly when erythema marginatum and subcutaneous nodules are present. We report a 13-year-old boy who fulfilled three major Jones manifestations—migratory polyarthritis, erythema marginatum, and subcutaneous nodules—supported by evidence of recent streptococcal infection, yet had no clinical, electrocardiographic, or echocardiographic evidence of carditis on serial assessment over three months. Serial photographs documented the evolving morphology of erythema marginatum in dark skin. A transient ocular inflammatory episode occurred during convalescence. This case highlights an uncommon phenotype of acute rheumatic fever and underscores the importance of recognising major extracardiac manifestations even when the heart remains unaffected.
- 30 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-4
When the skin speaks but the heart remains silent: acute rheumatic fever with three major Jones manifestations without carditis
Acute rheumatic fever is classically associated with carditis, particularly when erythema marginatum and subcutaneous nodules are present. We report a 13-year-old boy who fulfilled three major Jones manifestations—migratory polyarthritis, erythema marginatum, and subcutaneous nodules—supported by evidence of recent streptococcal infection, yet had no clinical, electrocardiographic, or echocardiographic evidence of carditis on serial assessment over three months. Serial photographs documented the evolving morphology of erythema marginatum in dark skin. A transient ocular inflammatory episode occurred during convalescence. This case highlights an uncommon phenotype of acute rheumatic fever and underscores the importance of recognising major extracardiac manifestations even when the heart remains unaffected.
- Open Access
- 19 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Look Before You Leap?
- 19 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Open AccessLook Before You Leap?
- Open Access
- 14 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Adolescent Survival in Thoracoabdominal Ectopia Cordis With Complex Single Ventricle Physiology and Complete Atrioventricular Block
- 14 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Open AccessAdolescent Survival in Thoracoabdominal Ectopia Cordis With Complex Single Ventricle Physiology and Complete Atrioventricular Block
- Open Access
- 31 July 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (4) , 437-442
Simultaneous transcatheter management of incidental critical left main coronary artery disease in a young woman undergoing atrial septal defect device closure
Transcatheter device closure is the preferred treatment for secundum atrial septal defect (ASD) in young adults with suitable anatomy. In this population, routine coronary angiography is generally not recommended in the absence of ischemic symptoms or conventional cardiovascular risk factors. However, coronary imaging is selectively performed during ASD intervention to delineate anomalous coronary anatomy at risk of device-related compression, and emerging evidence indicates that clinically significant coronary artery disease may occasionally coexist silently in younger adults. We report the case of a 28-year-old asymptomatic woman undergoing transcatheter closure of a large secundum ASD with deficient rims, in whom coronary angiography performed during invasive catheterization unexpectedly revealed critical left main coronary artery stenosis. Intravascular ultrasound (IVUS) confirmed severe luminal compromise, and successful IVUS-guided left main coronary stenting was performed, followed by device-assisted ASD closure in the same procedural session. Retrospective clinical assessment revealed a history of premature sudden cardiac death in a first-degree relative. This case illustrates the potential for occult yet prognostically significant coronary artery disease in young adults undergoing congenital heart interventions and supports a selective, individualized, and context-driven approach to coronary evaluation, consistent with contemporary adult congenital heart disease guidelines.
- 31 July 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (4) , 437-442
Open AccessSimultaneous transcatheter management of incidental critical left main coronary artery disease in a young woman undergoing atrial septal defect device closure
Transcatheter device closure is the preferred treatment for secundum atrial septal defect (ASD) in young adults with suitable anatomy. In this population, routine coronary angiography is generally not recommended in the absence of ischemic symptoms or conventional cardiovascular risk factors. However, coronary imaging is selectively performed during ASD intervention to delineate anomalous coronary anatomy at risk of device-related compression, and emerging evidence indicates that clinically significant coronary artery disease may occasionally coexist silently in younger adults. We report the case of a 28-year-old asymptomatic woman undergoing transcatheter closure of a large secundum ASD with deficient rims, in whom coronary angiography performed during invasive catheterization unexpectedly revealed critical left main coronary artery stenosis. Intravascular ultrasound (IVUS) confirmed severe luminal compromise, and successful IVUS-guided left main coronary stenting was performed, followed by device-assisted ASD closure in the same procedural session. Retrospective clinical assessment revealed a history of premature sudden cardiac death in a first-degree relative. This case illustrates the potential for occult yet prognostically significant coronary artery disease in young adults undergoing congenital heart interventions and supports a selective, individualized, and context-driven approach to coronary evaluation, consistent with contemporary adult congenital heart disease guidelines.
- Open Access
- 8 June 2026
- Published by Elsevier in JACC: Case Reports
- p. 108780
Thrombus-In-Transit Across Patent Foramen Ovale Causing Dynamic Embolism to the Left Main Coronary and Pulmonary Arteries
- 8 June 2026
- Published by Elsevier in JACC: Case Reports
- p. 108780
Open AccessThrombus-In-Transit Across Patent Foramen Ovale Causing Dynamic Embolism to the Left Main Coronary and Pulmonary Arteries
- 15 April 2026
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 82
Transcatheter closure of right coronary sinus to right ventricle inflow tunnel using the KONAR-MF occluder
- 15 April 2026
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 82
Transcatheter closure of right coronary sinus to right ventricle inflow tunnel using the KONAR-MF occluder
- Open Access
- 9 April 2026
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 7 (3) , 222-229
Off-label Use of the Aviator Plus Balloon in Infants with Left Heart Obstruction: A Single-center Early Experience
Background: Balloon dilation is an established option for selected left heart obstructive lesions in infants, traditionally using low-profile, low-pressure balloons. Experience with high-pressure, rapid-exchange systems such as the Aviator Plus in this age group remains limited. Objective: To describe feasibility, procedural performance, and early outcomes of off-label balloon dilation using the Aviator Plus platform in infants with coarctation of the aorta or valvular aortic stenosis. Methods: A retrospective review was performed of infants undergoing Aviator Plus balloon dilation between April 2024 and July 2025. Clinical features, procedural details, and follow-up outcomes were summarized descriptively. Results: Four infants (mean age 5.5 months; mean weight 5.87 kg) underwent intervention: three with native coarctation of the aorta and one with severe aortic stenosis. One coarctation of the aorta patient had significant left ventricular dysfunction; the aortic stenosis patient had moderate mitral regurgitation. Balloon dilation used a single 6 × 20 mm balloon in two cases and sequential 6 × 20 mm and 7 × 20 mm balloons in two. All procedures produced immediate gradient reduction. During a mean 8.5-month follow-up, one infant with aortic stenosis died from progression of mitral regurgitation and intercurrent infection, and one coarctation of the aorta patient required surgical repair for re-coarctation. The remaining infants maintained gradient relief with preserved ventricular function. Conclusions: This early experience suggests that the Aviator Plus balloon can be a feasible off-label option for carefully selected infants with left heart obstruction, particularly where pediatric-specific balloons are limited. Larger series with extended follow-up are needed to define long-term outcomes.
- 9 April 2026
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 7 (3) , 222-229
Open AccessOff-label Use of the Aviator Plus Balloon in Infants with Left Heart Obstruction: A Single-center Early Experience
Background: Balloon dilation is an established option for selected left heart obstructive lesions in infants, traditionally using low-profile, low-pressure balloons. Experience with high-pressure, rapid-exchange systems such as the Aviator Plus in this age group remains limited. Objective: To describe feasibility, procedural performance, and early outcomes of off-label balloon dilation using the Aviator Plus platform in infants with coarctation of the aorta or valvular aortic stenosis. Methods: A retrospective review was performed of infants undergoing Aviator Plus balloon dilation between April 2024 and July 2025. Clinical features, procedural details, and follow-up outcomes were summarized descriptively. Results: Four infants (mean age 5.5 months; mean weight 5.87 kg) underwent intervention: three with native coarctation of the aorta and one with severe aortic stenosis. One coarctation of the aorta patient had significant left ventricular dysfunction; the aortic stenosis patient had moderate mitral regurgitation. Balloon dilation used a single 6 × 20 mm balloon in two cases and sequential 6 × 20 mm and 7 × 20 mm balloons in two. All procedures produced immediate gradient reduction. During a mean 8.5-month follow-up, one infant with aortic stenosis died from progression of mitral regurgitation and intercurrent infection, and one coarctation of the aorta patient required surgical repair for re-coarctation. The remaining infants maintained gradient relief with preserved ventricular function. Conclusions: This early experience suggests that the Aviator Plus balloon can be a feasible off-label option for carefully selected infants with left heart obstruction, particularly where pediatric-specific balloons are limited. Larger series with extended follow-up are needed to define long-term outcomes.
- 8 April 2026
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 82
Transcatheter fenestrated closure of large secundum atrial septal defects in complex anatomy and physiology
- 8 April 2026
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 82
Transcatheter fenestrated closure of large secundum atrial septal defects in complex anatomy and physiology
- 22 January 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (1) , 27-39
Multicenter study on transcatheter closure of large secundum atrial septal defects using 40–50 mm septal occluders
Objective: Transcatheter closure of secundum atrial septal defects is well-established, but data on very large defects requiring 40–50 mm occluders remain limited. This multicenter retrospective study evaluated the safety and efficacy of percutaneous closure using large atrial septal occluders. Methods: Patients undergoing atrial septal defect device closure with 40–50 mm occluders from June 2015 to May 2025 at two tertiary centres were analysed. Patients were grouped by device size: Group A (40–42 mm; n = 34) and Group B (44–50 mm; n = 28). Results: The cohort ( n = 62) had a mean age of 42.07 years with female predominance (70.96%). Mean atrial septal defect size was 33.03 mm (thick-to-thick: 38.71 mm), with mean pulmonary artery pressure of 22.33 mmHg and left ventricular end-diastolic pressure of 12.59 mmHg. Aneurysmal septum with thin or deficient posteroinferior rim was common (77.4% and 19.4%, respectively). Procedural success was 93.5%. Device instability or residual flow led to surgical closure in three cases; one had intraprocedural embolisation. Procedural assistance (balloon/device, etc.) was needed in 93.5%. Fenestrated devices were used in four (6.5%) patients—due to severe pulmonary stenosis, diastolic dysfunction, or pulmonary hypertension. “Cobra” configuration and device bulkiness were noted in 9.7% and 6.5%, respectively. Arrhythmias occurred in 25.8%, mostly transient. One patient developed device-related endocarditis, and one late, unrelated death occurred due to intracranial haemorrhage. At a mean follow-up of 29.29 months, outcomes were satisfactory. Conclusion: Transcatheter closure of large atrial septal defects with 40–50 mm devices is safe and effective with proper anatomical assessment, procedural planning, and vigilant follow-up in selected patients.
- 22 January 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (1) , 27-39
Multicenter study on transcatheter closure of large secundum atrial septal defects using 40–50 mm septal occluders
Objective: Transcatheter closure of secundum atrial septal defects is well-established, but data on very large defects requiring 40–50 mm occluders remain limited. This multicenter retrospective study evaluated the safety and efficacy of percutaneous closure using large atrial septal occluders. Methods: Patients undergoing atrial septal defect device closure with 40–50 mm occluders from June 2015 to May 2025 at two tertiary centres were analysed. Patients were grouped by device size: Group A (40–42 mm; n = 34) and Group B (44–50 mm; n = 28). Results: The cohort ( n = 62) had a mean age of 42.07 years with female predominance (70.96%). Mean atrial septal defect size was 33.03 mm (thick-to-thick: 38.71 mm), with mean pulmonary artery pressure of 22.33 mmHg and left ventricular end-diastolic pressure of 12.59 mmHg. Aneurysmal septum with thin or deficient posteroinferior rim was common (77.4% and 19.4%, respectively). Procedural success was 93.5%. Device instability or residual flow led to surgical closure in three cases; one had intraprocedural embolisation. Procedural assistance (balloon/device, etc.) was needed in 93.5%. Fenestrated devices were used in four (6.5%) patients—due to severe pulmonary stenosis, diastolic dysfunction, or pulmonary hypertension. “Cobra” configuration and device bulkiness were noted in 9.7% and 6.5%, respectively. Arrhythmias occurred in 25.8%, mostly transient. One patient developed device-related endocarditis, and one late, unrelated death occurred due to intracranial haemorrhage. At a mean follow-up of 29.29 months, outcomes were satisfactory. Conclusion: Transcatheter closure of large atrial septal defects with 40–50 mm devices is safe and effective with proper anatomical assessment, procedural planning, and vigilant follow-up in selected patients.
- 5 August 2025
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 32 (5) , 207-210
Transcatheter closure of anomalous systemic arterial supply to the left lung from the left subclavian artery: Diagnostic and procedural challenges
- 5 August 2025
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 32 (5) , 207-210
Transcatheter closure of anomalous systemic arterial supply to the left lung from the left subclavian artery: Diagnostic and procedural challenges